Ceftriaxone
Ceftriaxone for Injection, USP
Approved
Approval ID
7bed9b33-29e3-4f04-9766-43a21c7ad47a
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Oct 24, 2023
Manufacturers
FDA
WG Critical Care, LLC
DUNS: 829274633
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Ceftriaxone
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code44567-702
Application NumberANDA065329
Product Classification
M
Marketing Category
C73584
G
Generic Name
Ceftriaxone
Product Specifications
Route of AdministrationINTRAVENOUS, INTRAMUSCULAR
Effective DateOctober 24, 2023
FDA Product Classification
INGREDIENTS (2)
CEFTRIAXONE SODIUMActive
Quantity: 2 g in 1 1
Code: 023Z5BR09K
Classification: ACTIM
NATURAL LATEX RUBBERInactive
Quantity: 0 1 in 1 1
Code: 2LQ0UUW8IN
Classification: CNTM
Ceftriaxone
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code44567-701
Application NumberANDA065329
Product Classification
M
Marketing Category
C73584
G
Generic Name
Ceftriaxone
Product Specifications
Route of AdministrationINTRAVENOUS, INTRAMUSCULAR
Effective DateOctober 24, 2023
FDA Product Classification
INGREDIENTS (2)
CEFTRIAXONE SODIUMActive
Quantity: 1 g in 1 1
Code: 023Z5BR09K
Classification: ACTIM
NATURAL LATEX RUBBERInactive
Quantity: 0 1 in 1 1
Code: 2LQ0UUW8IN
Classification: CNTM